相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intracellular transport of recombinant adeno-associated virus vectors
M. Nonnenmacher et al.
GENE THERAPY (2012)
Multisite Phosphorylation of Human Liver Cytochrome P450 3A4 Enhances Its gp78- and CHIP-mediated Ubiquitination
YongQiang Wang et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors
George V. Aslanidi et al.
VACCINE (2012)
Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences
Christine Aurnhammer et al.
HUMAN GENE THERAPY METHODS (2012)
Gene therapy for haemophilia: a long and winding road
K. A. High
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2011)
Defining the geometry of the two-component proteasome degron
Tomonao Inobe et al.
NATURE CHEMICAL BIOLOGY (2011)
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
Thomas Force et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
Federico Mingozzi et al.
NATURE REVIEWS GENETICS (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
High-Efficiency Transduction of Fibroblasts and Mesenchymal Stem Cells by Tyrosine-Mutant AAV2 Vectors for Their Potential Use in Cellular Therapy
Mengxin Li et al.
HUMAN GENE THERAPY (2010)
Enhanced Long-Term Transduction and Multilineage Engraftment of Human Hematopoietic Stem Cells Transduced with Tyrosine-Modified Recombinant Adeno-Associated Virus Serotype 2
M. Ariel Kauss et al.
HUMAN GENE THERAPY (2010)
Proteasome Inhibitors Enhance Gene Delivery by AAV Virus Vectors Expressing Large Genomes in Hemophilia Mouse and Dog Models: A Strategy for Broad Clinical Application
Paul E. Monahan et al.
MOLECULAR THERAPY (2010)
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
Francesca Simonelli et al.
MOLECULAR THERAPY (2010)
Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses
Roberto Calcedo et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
A New Genetic Vaccine Platform Based on an Adeno-Associated Virus Isolated from a Rhesus Macaque
Jianping Lin et al.
JOURNAL OF VIROLOGY (2009)
High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2009)
Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients
Erik S. Stroes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo
G. R. Jayandharan et al.
GENE THERAPY (2008)
Recent developments in adeno-associated virus vector technology
Hildegard Buening et al.
JOURNAL OF GENE MEDICINE (2008)
DNA shuffling of adeno-associated virus yields functionally diverse viral progeny
James T. Koerber et al.
MOLECULAR THERAPY (2008)
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
Carmela Zincarelli et al.
MOLECULAR THERAPY (2008)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
Li Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression
Li Zhong et al.
VIROLOGY (2008)
Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors
Weihong Zhao et al.
VIROLOGY (2006)
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs
HY Jiang et al.
BLOOD (2006)
Proteasome inhibition induces reversible impairments in protein synthesis
Qunxing Ding et al.
FASEB JOURNAL (2006)
Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin binding ability and introduced novel tropism
XQ Shi et al.
HUMAN GENE THERAPY (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization
MA Lochrie et al.
JOURNAL OF VIROLOGY (2006)
Adeno-associated virus types 5 and 6 use distinct receptors for cell entry
MP Seiler et al.
HUMAN GENE THERAPY (2006)
AAV hybrid serotypes: Improved vectors for gene delivery
VW Choi et al.
CURRENT GENE THERAPY (2005)
Proteasome inhibition as a novel therapeutic target in human cancer
SV Rajkumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection
Y Kashiwakura et al.
JOURNAL OF VIROLOGY (2005)
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
A Kern et al.
JOURNAL OF VIROLOGY (2003)
Multiple sequence alignment with the Clustal series of programs
R Chenna et al.
NUCLEIC ACIDS RESEARCH (2003)
Structure of a β-TrCP1-Skp1-β-catenin complex:: Destruction motif binding and lysine specificity of the SCFβ-TrCP1 ubiquitin ligase
G Wu et al.
MOLECULAR CELL (2003)
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding
SR Opie et al.
JOURNAL OF VIROLOGY (2003)
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Q Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity
A Girod et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors
ZY Yan et al.
JOURNAL OF VIROLOGY (2002)
Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity
N Kaludov et al.
JOURNAL OF VIROLOGY (2001)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
